U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07651891) titled 'Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice' on June 11.

Brief Summary: STUDY DESIGN A single center case-control study evaluating the effect of Alutard SQ dog among 40 healthy men and women with moderate- to severe dog allergic patients. Recruited patients will be their own controls.

STUDY OUTLINE The study will begin during the fall 2026. The trial will run over a one-year period. Patients will be asked to register allergic symptoms (base line), lungfunction and nasal breathing will be tested. Bloodsamples will be taken. Shortly after they will be provoked by entering a facility contai...